✦ LIBER ✦
7131 POSTER Optimizing the Sequencial Treatment of Metastatic Renal Cell Carcinoma (MRCC) – a Retrospective, Multicenter, Analysis of 40 Patients Treated With Either Sorafenib, an mTOR Inhibitor (mTORI) and Sunitinib, or Sunitinib, an mTORI and Sorafenib
✍ Scribed by Porta, C.; Paglino, C.; Procopio, G.; Sabbatini, R.; Bellmunt, J.; Schmidinger, M.; Bearz, A.; Bamias, A.; Melichar, B.; Imarisio, I.
- Book ID
- 123425827
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 42 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.